150 related articles for article (PubMed ID: 7811827)
21. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.
Banito A; Pinto AE; Espadinha C; Marques AR; Leite V
Clin Endocrinol (Oxf); 2007 Nov; 67(5):706-11. PubMed ID: 17651453
[TBL] [Abstract][Full Text] [Related]
22. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
[TBL] [Abstract][Full Text] [Related]
23. The measurement of DNA content and ploidy analysis in thyroid neoplasms.
McLeod MK
Otolaryngol Clin North Am; 1990 Apr; 23(2):271-90. PubMed ID: 2186336
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
[TBL] [Abstract][Full Text] [Related]
26. Significance of trisomy 7 and 12 in thyroid lesions with follicular differentiation: a cytogenetic and in situ hybridization study.
Roque L; Serpa A; Clode A; Castedo S; Soares J
Lab Invest; 1999 Apr; 79(4):369-78. PubMed ID: 10211989
[TBL] [Abstract][Full Text] [Related]
27. A comparative study of flow cytometry and histopathologic findings in thyroid follicular carcinomas and adenomas.
Oyama T; Vickery AL; Preffer FI; Colvin RB
Hum Pathol; 1994 Mar; 25(3):271-5. PubMed ID: 8150457
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
29. [Small thyroid carcinomas: biological characteristics, diagnosis and therapy].
Gemsenjäger E; Schweizer I
Schweiz Med Wochenschr; 1999 May; 129(18):681-90. PubMed ID: 10407941
[TBL] [Abstract][Full Text] [Related]
30. DNA aneuploidy in follicular thyroid neoplasia.
Cusick EL; Ewen SW; Krukowski ZH; Matheson NA
Br J Surg; 1991 Jan; 78(1):94-6. PubMed ID: 1998875
[TBL] [Abstract][Full Text] [Related]
31. The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.
Fukahori M; Yoshida A; Hayashi H; Yoshihara M; Matsukuma S; Sakuma Y; Koizume S; Okamoto N; Kondo T; Masuda M; Miyagi Y
Thyroid; 2012 Jul; 22(7):683-9. PubMed ID: 22650231
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
[TBL] [Abstract][Full Text] [Related]
33. Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings.
Lang W; Choritz H; Hundeshagen H
Am J Surg Pathol; 1986 Apr; 10(4):246-55. PubMed ID: 3706611
[TBL] [Abstract][Full Text] [Related]
34. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
[TBL] [Abstract][Full Text] [Related]
36. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.
Zhao J; Leonard C; Gemsenjäger E; Heitz PU; Moch H; Odermatt B
Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778
[TBL] [Abstract][Full Text] [Related]
38. Frequency and degree of aneuploidy in benign and malignant thyroid neoplasms.
Schelfhout LJ; Cornelisse CJ; Goslings BM; Hamming JF; Kuipers-Dijkshoorn NJ; van de Velde CJ; Fleuren GJ
Int J Cancer; 1990 Jan; 45(1):16-20. PubMed ID: 2298499
[TBL] [Abstract][Full Text] [Related]
39. Follicular variant of papillary thyroid carcinoma: a long-term follow-up.
Passler C; Prager G; Scheuba C; Niederle BE; Kaserer K; Zettinig G; Niederle B
Arch Surg; 2003 Dec; 138(12):1362-6. PubMed ID: 14662540
[TBL] [Abstract][Full Text] [Related]
40. A novel microdissection and genotyping of follicular-derived thyroid tumors to predict aggressiveness.
Hunt JL; Livolsi VA; Baloch ZW; Swalsky PA; Bakker A; Sasatomi E; Finkelstein S; Barnes EL
Hum Pathol; 2003 Apr; 34(4):375-80. PubMed ID: 12733119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
